A MULTIANTIGEN VACCINE (STEMVAC) FOR ADJUVANT TREATMENT OF PATIENTS WITH MODERATE OR EXTENSIVE RESIDUAL TRIPLE-NEGATIVE BREAST CANCER
$6,965,603FY2025Defense Health AgencyDOD
University Of Washington, Seattle WA
Investigators
View source on USAspending →A MULTIANTIGEN VACCINE (STEMVAC) FOR ADJUVANT TREATMENT OF PATIENTS WITH MODERATE OR EXTENSIVE RESIDUAL TRIPLE-NEGATIVE BREAST CANCER · GrantIndex